Metabolon Technology Now Available in Germany
Complete the form below to unlock access to ALL audio articles.
The Helmholtz Zentrum Muenchen-Metabolon Joint Metabolomics Laboratory has successfully passed a series of stringent quality control processes and reviews, and has officially begun operations. Validation of this lab follows closely behind Shanghai Jiao Tong University Lab in China, which received the Company’s validation last month. The Helmholtz Zentrum Muenchen validation will further expand Metabolon’s commercial sample processing scope and gives the Company an important entry into the European market. This comes after the publication of “Human Metabolic Individuality in Biomedical and Pharmaceutical Research” in the journal Nature in 2011, which was carried out by researchers at the Helmholtz Zentrum Muenchen, the Wellcome Trust/Sanger Centre, King’s College and Metabolon, Inc.
“This is Metabolon’s second successful joint lab launch and fully demonstrates the organization’s commitment to replicating our mass spectrometry process for the benefit of metabolomics research,” stated Metabolon CEO John Ryals.
